These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 11112863)
1. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Cataldo D; Munaut C; Noël A; Frankenne F; Bartsch P; Foidart JM; Louis R Int Arch Allergy Immunol; 2000 Nov; 123(3):259-67. PubMed ID: 11112863 [TBL] [Abstract][Full Text] [Related]
2. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation]. Xin XF; Zhao M; Li ZL; Song Y; Shi Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998 [TBL] [Abstract][Full Text] [Related]
4. [MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma]. Calikoğlu M; Unlü A; Tamer L; Ozgür E Tuberk Toraks; 2006; 54(2):114-21. PubMed ID: 16924566 [TBL] [Abstract][Full Text] [Related]
5. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Vignola AM; Riccobono L; Mirabella A; Profita M; Chanez P; Bellia V; Mautino G; D'accardi P; Bousquet J; Bonsignore G Am J Respir Crit Care Med; 1998 Dec; 158(6):1945-50. PubMed ID: 9847290 [TBL] [Abstract][Full Text] [Related]
6. Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma. Park HS; Kim HA; Jung JW; Kim YK; Lee SK; Kim SS; Nahm DH Clin Exp Allergy; 2003 Jan; 33(1):113-8. PubMed ID: 12534559 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and TIMP-1 production by peripheral blood granulocytes from COPD patients and asthmatics. Cataldo D; Munaut C; Noël A; Frankenne F; Bartsch P; Foidart JM; Louis R Allergy; 2001 Feb; 56(2):145-51. PubMed ID: 11167375 [TBL] [Abstract][Full Text] [Related]
9. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Beeh KM; Beier J; Kornmann O; Buhl R Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147 [TBL] [Abstract][Full Text] [Related]
10. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models]. Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602 [TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Mattos W; Lim S; Russell R; Jatakanon A; Chung KF; Barnes PJ Chest; 2002 Nov; 122(5):1543-52. PubMed ID: 12426251 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Cataldo DD; Bettiol J; Noël A; Bartsch P; Foidart JM; Louis R Chest; 2002 Nov; 122(5):1553-9. PubMed ID: 12426252 [TBL] [Abstract][Full Text] [Related]
13. Localization of MMP-2, MMP-9, TIMP-1, and TIMP-2 in human coronal dentine. Niu LN; Zhang L; Jiao K; Li F; Ding YX; Wang DY; Wang MQ; Tay FR; Chen JH J Dent; 2011 Aug; 39(8):536-42. PubMed ID: 21641958 [TBL] [Abstract][Full Text] [Related]
14. The role of noninvasive methods in assessing airway inflammation and structural changes in asthma and COPD. Dar KA; Shahid M; Mubeen A; Bhargava R; Ahmad Z; Ahmad I; Islam N Monaldi Arch Chest Dis; 2012 Mar; 77(1):8-18. PubMed ID: 22662640 [TBL] [Abstract][Full Text] [Related]
15. Clinical study of inflammatory factors in sputum induced early after lung volume reduction surgery. Miao JB; Hou SC; Li H; Hu B; Wang TY Chin Med J (Engl); 2008 Sep; 121(18):1796-9. PubMed ID: 19080360 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis. Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734 [TBL] [Abstract][Full Text] [Related]
17. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. Tanaka H; Miyazaki N; Oashi K; Tanaka S; Ohmichi M; Abe S J Allergy Clin Immunol; 2000 May; 105(5):900-5. PubMed ID: 10808169 [TBL] [Abstract][Full Text] [Related]
18. Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma. Chaudhuri R; McSharry C; Brady J; Grierson C; Messow CM; Spears M; Miele G; Nocka K; MacNee W; Connell M; Murchison JT; Sproule M; Hilmi OJ; Miller DK; Thomson NC Eur Respir J; 2014 Oct; 44(4):895-904. PubMed ID: 24993912 [TBL] [Abstract][Full Text] [Related]
19. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Vernooy JH; Lindeman JH; Jacobs JA; Hanemaaijer R; Wouters EF Chest; 2004 Dec; 126(6):1802-10. PubMed ID: 15596677 [TBL] [Abstract][Full Text] [Related]
20. [Markers of airway remodeling in induced sputum from healthy smokers]. Avilés B; Belda J; Margarit G; Bellido-Casado J; Martínez-Brú C; Casan P Arch Bronconeumol; 2006 May; 42(5):235-40. PubMed ID: 16740239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]